2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2019-08, Vol.140 (8), p.e333-e381
Hauptverfasser:	Kusumoto, Fred M, Schoenfeld, Mark H, Barrett, Coletta, Edgerton, James R, Ellenbogen, Kenneth A, Gold, Michael R, Goldschlager, Nora F, Hamilton, Robert M, Joglar, José A, Kim, Robert J, Lee, Richard, Marine, Joseph E, McLeod, Christopher J, Oken, Keith R, Patton, Kristen K, Pellegrini, Cara N, Selzman, Kimberly A, Thompson, Annemarie, Varosy, Paul D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Agonists - therapeutic use Algorithms Bradycardia - diagnosis Bradycardia - genetics Bradycardia - therapy Bronchodilator Agents - therapeutic use Calcium Channel Blockers - therapeutic use Cardiac Conduction System Disease - diagnosis Cardiac Conduction System Disease - genetics Cardiac Conduction System Disease - therapy Cardiotonic Agents - therapeutic use Electrocardiography - methods Genetic Testing - methods Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!